| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 22,572 | 22,077 | 21,652 | 20,474 | | Cost of Revenue | 14,402 | 14,598 | 13,205 | 11,874 | | | Gross Profit | 8,170 | 7,479 | 8,447 | 8,600 | | | Operating Expenses | | Research Development | 2,178 | 2,592 | 2,648 | 2,757 | | Selling General and Administrative | 8,347 | 9,158 | 9,216 | 9,337 | | Non Recurring | 1,295 | 3,867 | 107 | 9,663 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,650) | (8,138) | (3,524) | (13,157) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 10,324 | 3,344 | (2,105) | 3,669 | | Earnings Before Interest And Taxes | 6,674 | (4,794) | (5,629) | (9,488) | | Interest Expense | 49 | 73 | 84 | 128 | | Income Before Tax | 6,625 | (4,867) | (5,713) | (9,616) | | Income Tax Expense | 516 | 421 | (53) | 288 | | Minority Interest | (1,006) | 392 | (392) | (812) | | | | Net Income From Continuing Ops | 2,342 | (7,820) | (11,005) | (26,576) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,342 | (7,820) | (11,005) | (26,576) | | Preferred Stock And Other Adjustments | 729 | (729) |
-
|
-
| | | Net Income Applicable To Common Shares | $3,071 | ($8,549) | ($11,005) | ($26,576) |
|
1.27% Nasdaq 
Income Statement
